4.5 Article

Implication of sphingosin-1-phosphate in cardiovascular regulation

Journal

FRONTIERS IN BIOSCIENCE-LANDMARK
Volume 21, Issue -, Pages 1296-1313

Publisher

BIOSCIENCE RESEARCH INST-BRI
DOI: 10.2741/4458

Keywords

Review; Sphingosine Kinase; Blood Pressure; Cardiac Remodeling; Atherosclerosis; Sodium Excretion; Vascular Tone; Endothelial Permeability

Funding

  1. National Institutes of Health [HL-89563, HL106042, HL115068]

Ask authors/readers for more resources

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite generated by phosphorylation of sphingosine catalyzed by sphingosine kinase. S1P acts mainly through its high affinity G-protein-coupled receptors and participates in the regulation of multiple systems, including cardiovascular system. It has been shown that S1P signaling is involved in the regulation of cardiac chronotropy and inotropy and contributes to cardioprotection as well as cardiac remodeling; S1P signaling regulates vascular function, such as vascular tone and endothelial barrier, and possesses an antiatherosclerotic effect; S1P signaling is also implicated in the regulation of blood pressure. Therefore, manipulation of S1P signaling may offer novel therapeutic approaches to cardiovascular diseases. As several S1P receptor modulators and sphingosine kinase inhibitors have been approved or under clinical trials for the treatment of other diseases, it may expedite the test and implementation of these S1P-based drugs in cardiovascular diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available